Transforming the Future

 Wild Boar Biosciences is focused on developing innovative therapeutics to target inflammation by leveraging the unique mechanism of sialic acid-binding immunotherapeutic receptors, specifically siglecs and selectins.  

 Our approach offers a more targeted and potentially safer alternative to conventional anti-inflammatory therapies, minimizing side effects while enhancing the body's natural immune regulation. Through cutting-edge research and development, the company seeks to revolutionize the treatment of inflammation-related disorders  

At Wild Boar Biosciences , we foster a culture of creativity, collaboration, and excellence. We believe in supporting our team members and empowering them to achieve their full potential. We also value diversity and inclusivity in all aspects of our work.